Detail of GM0183
Summary
The genetically modified enzybiotic, named SAL-1D3 , constructed by Mutagenesis strategy, keep the lytic activity.With SAL-1D3
Sequence Length: 495 AA.
Mass: 54778.6 Da.
Isoelectric Point: 9.93
Function:
Construction
GM0183, constructed by Mutagenesis strategy. No schema construted on GM0183
Details:
GM0183[1-495]: derive from protein I6X5A8 sequence 1-495
I6X5A8, 495 AA., the LysK from Staphylococcus phage Fi200W
Source: Staphylococcus phage Fi200W
196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
Linking to UniprotKB
Linging to InterPro
Domains and repeats
29-160: IPR007921, the CHAP domain196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
GO term prediction
Molecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activityLinking to UniprotKB
Linging to InterPro
Annotation
1-495
45-159
: EAD, CHAP domain, derived from S. aureus bacteriophage SAP-1 endolysin SAL-1;207-335
: EAD, PGRR domain, derived from S. aureus bacteriophage SAP-1 endolysin SAL-1;409-475
: CBD, SH3_5 domain, derived from S. aureus bacteriophage SAP-1 endolysin SAL-1;26
: MUT, mutation with V26I ;486
: MUT, mutation with I486H ;Domain and repeats:
196-369
: IPR002502,N-acetylmuramoyl-L-alanine amidase domain; 29-160
: IPR007921,CHAP domain; 409-481
: IPR003646,SH3-like domain, bacterial-type?; GO term prediction:
0008745, the N-acetylmuramoyl-L-alanine amidase activity
0009253, the peptidoglycan catabolic process
MAKTQAEINKRLDAYAKGTVDSPYRIKKATSYDPSFGVMEAGAIDADGYYHAQCQDLITDYVLWLTDNKVRTWGNAKDQIKQSYGTGFKIHENKPSTVPKKGWIAVFTSGSYEQWGHIGIVYDGGNTSTFTILEQNWNGYANKKPTKRVDNYYGLTHFIEIPVKAGTTVKKETAKKSASKTPAPKKKATLKVSKNHINYTMDKRGKKPEGMVIHNDAGRSSGQQYENSLANAGYARYANGIAHYYGSEGYVWEAIDAKNQIAWHTGDGTGANSGNFRFAGIEVCQSMSASDAQFLKNEQAVFQFTAEKFKEWGLTPNRKTVRLHMEFVPTACPHRSMVLHTGFNPVTQGRPSQAIMNKLKDYFIKQIKNYMDKGTSSSTVVKDGKTSSASTPATRPVTGSWKKNQYGTWYKPENATFVNGNQPIVTRIGSPFLNAPVGGNLPAGATIVYDEVCIQAGHIWIGYNAYNGNRVYCPVRTCQGVPPNQHPGVAWGVFK